EL · Estee Lauder Companies

The thesis

Estée Lauder's turnaround now shows in sales as well as margins, which gives the shares a modest edge over the S&P 500 while the company rebuilds its earnings. First-quarter organic sales rose 6% and the fiscal 2027 outlook went up again. The fiscal second-quarter report, estimated for about 3 February 2027, will show whether growth holds against harder comparisons in the second half.

The company's 2 November 2026 release covers the July–September quarter. Net sales rose 7% to $3.715 billion and organic sales rose 6%. Organic sales exclude currency moves, acquisitions and divestitures. Adjusted operating margin rose 4.8 percentage points to 12.1%. Adjusted earnings per share (EPS) were $0.72, against $0.32 a year earlier.

The company raised its fiscal 2027 outlook the same day. Organic growth moved to 4.0%–5.5% from 3%–5%, adjusted operating margin to 12.9%–13.7% from 12.7%–13.5%, and adjusted EPS to $3.20–$3.45 from $3.10–$3.35. On 4 November 2026 its 8-K added fiscal 2030 targets: mid-single-digit organic growth, a 16.5%–18.5% adjusted operating margin and double-digit adjusted EPS growth.

Three things have happened since the report. Citigroup raised its target to $132 from $121 on 10 November 2026, per Benzinga. Directors and senior executives, the chief executive among them, sold shares between $108.63 and $115.10 from 5 November to 9 November 2026, per SEC Form 4 filings. Justin Boxford, Global President of Luxury Beauty Brands, is leaving to become chief executive of Capri Holdings on 4 January 2027, per Capri's 8-K of 11 November 2026. The shares closed at $112.33 on 11 November 2026. That is above the $110 and $112 targets of Wells Fargo and UBS and below Citigroup's $132. The price already reflects the first-quarter beat and the raised outlook, but only part of the fiscal 2030 margin target.

Bullish and bearish views on The Estee Lauder Companies Inc.

The bull case on The Estee Lauder Companies Inc. (EL), in brief: sales beat consensus and cautious previews. The bear case: insiders sold into the rally.

Bull case

• Sales beat consensus and cautious previews. Revenue of $3.72 billion compared with a $3.64 billion consensus, per InvestorsHub on 2 November 2026. The 6% organic growth beat UBS's 4.5% forecast of 26 October 2026.
• Margins rose faster than sales. Adjusted gross margin reached 75.7%, up from 73.3%, per the 2 November 2026 release. Adjusted EPS of $0.72 compared with a $0.51 consensus, per InvestorsHub.
• Growth reached the West. The Americas and the Europe, UK and emerging markets region each grew 4% organically in the first quarter, against 1% each for all of fiscal 2026, per the 2 November 2026 release. The release expects stronger growth in the Europe, UK and emerging markets region in the second half.
• Mainland China kept its pace. Mainland China organic sales rose 9% to $614 million in the first quarter, matching fiscal 2026's 9%, per the 2 November 2026 release. Asia/Pacific organic sales rose 10%, which the release credits mainly to Asia travel retail.
• Fiscal 2030 targets extend the margin case. The 16.5%–18.5% adjusted operating margin target compares with 11.2% in fiscal 2026, per the 4 November 2026 8-K exhibit. The company also expects free cash flow to rise through fiscal 2030.
• Targets kept rising after the report. Citigroup raised its target to $132 from $121 on 10 November 2026 and kept a Buy rating, per Benzinga. Barclays and RBC moved to $126 on 3 November 2026 and 4 November 2026, per Benzinga and The Fly.

Bear case

• Insiders sold into the rally. Director Paul J. Fribourg sold 90,972 shares at an average of $110.62 on 5 November 2026 and 6 November 2026, and 2,406 more at $115.10 on 9 November 2026, per SEC Form 4 filings. Chief executive Stéphane de la Faverie sold 9,100 shares at $112.97 on 9 November 2026, and general counsel Rashida La Lande sold 8,879 at an average of $113.84 the same day.
• A senior brand leader is leaving. The company said on 9 November 2026 that Justin Boxford, recently promoted to Global President of Luxury Beauty Brands, is departing. Capri's 11 November 2026 8-K says he previously led La Mer and more than doubled its size.
• The second half faces harder comparisons. The 2 November 2026 release expects growth to be stronger in the first half than in the second. Finviz coverage of the call says management expects tougher comparisons in Asia travel retail and China.
• The guidance raise trailed the quarter's beat. The adjusted EPS range moved up $0.10 at both ends, while first-quarter adjusted EPS beat consensus by $0.21, per the 2 November 2026 release and InvestorsHub.
• Growth leans on fragrance. First-quarter organic sales rose 20% in fragrance, against 4% in skin care, 1% in makeup and flat hair care, per the 2 November 2026 release.
• Cash flow is still weak. First-quarter free cash flow was negative $235 million, per the release. Fiscal 2027 operating cash flow guidance of $1.4–$1.5 billion is expected to decline from fiscal 2026.

Price setup

The shares closed at $112.33 on 11 November 2026, 7.7% below the 52-week intraday high of $121.64 set on 3 February 2026. The 52-week closing low was $67.23 on 27 March 2026. The shares are up 29.1% over three months, per adjusted daily closes.

On 11 November 2026 the 50-day moving average stood at $101.39 and the 200-day at $90.90. The shares have held above both since the report. They closed at $112.04 on 4 November 2026, dipped to $107.65 on 5 November 2026, and closed between $110.06 and $113.43 from 6 November to 11 November 2026.

The November insider sales all fall between $108.63 and $115.10, inside the range since the report. Director Fribourg's September sale averaged $98.17, per SEC Form 4 filings summarised by MarketBeat. That level sits between the 50-day and 200-day averages. A fall back toward it would erase most of the post-report gain.

Catalysts ahead

• 17 November 2026: 2026 Annual Meeting of Stockholders, held virtually. A governance event with shareholder votes; the case turns on the February results rather than on the vote.
• 15 December 2026: Payment of the $0.35 quarterly dividend to holders of record on 30 November 2026. A scheduled cash return with no bearing on the growth question.
• ~3 February 2027 (est.): Fiscal 2027 second-quarter results. Closes the half management expects to be stronger and shows whether organic growth stays above the 4% low end of guidance and whether the $3.20–$3.45 adjusted EPS range holds before harder second-half comparisons.

What would change the view

A daily close below $90, under the 200-day moving average and the $98.17 average price of a director's September sale, which would erase the post-report gain; or second-quarter organic growth below 4%, or a cut to the $3.20–$3.45 fiscal 2027 adjusted EPS guidance.

The risks this note tracks, each with what would confirm it:

• Asia travel retail and China growth slow against tougher second-half comparisons, removing the main source of the raised outlook. Confirmed by: mainland China organic growth falling to low single digits at the second-quarter report, or management trimming second-half commentary on the call.
• The raised outlook mostly passes through the first-quarter beat, leaving the remaining quarters no stronger than before. Confirmed by: second-quarter organic growth below 4%, or no further raise to the $3.20–$3.45 adjusted EPS range at the second-quarter report.
• Fragrance growth fades and skin care and makeup do not take over, after first-quarter organic growth of 20%, 4% and 1% respectively. Confirmed by: fragrance organic growth slowing sharply at the second-quarter report while makeup stays near flat.
• The departure of the Global President of Luxury Beauty Brands disrupts the luxury skin care brands, including La Mer, during the turnaround. Confirmed by: skin care organic growth falling below the first quarter's 4% at the second-quarter report, or further senior brand departures.
• Insider selling continues as the shares hold near post-report levels, adding supply and signalling limited management conviction at these prices. Confirmed by: further open-market Form 4 sales by directors or executive officers through December 2026.
• Tariffs or geopolitical tension hit costs or demand; the fiscal 2027 outlook assumes no deterioration and gives no tariff figure. Confirmed by: new US tariff actions on cosmetics imports, or management quantifying a tariff headwind at the second-quarter report.

What it trades with

The shares trade with the consumer staples and prestige beauty group. Benzinga reported in October 2026 that the rotation into staples over technology was the widest since February 2001. A reversal would weigh on the shares whatever the company reports.

The company's own drivers are China demand and Asia travel retail, including Hainan and the Beijing and Shanghai airports, per the 2 November 2026 release. Chinese consumer data and travel retail traffic move the shares more than US consumer data does. The fiscal 2027 outlook assumes no worsening in tariffs or geopolitical conditions and gives no tariff figure.